The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes

Molecular and Cellular Biochemistry

Volumn 322, Issue 1-2, 2009, Pages 87-91

  Liu, Limei ^a   Zheng, Taishan ^a   Wang, Niansong ^a   Wang, Feng ^a   Li, Ming ^a   Jiang, Jiamei ^a   Zhao, Ruie ^a   Li, Lifang ^a   Zhao, Weijing ^a   Zhu, Qihan ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Diabetic nephropathy (DN); Manganese superoxide dismutase (Mn SOD); Type 2 diabetes mellitus (T2DM); Val16Ala polymorphism (V16A)

Indexed keywords

ALANINE; ALBUMIN; HEMOGLOBIN A1C; MANGANESE SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VALINE;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RENAL PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ALANINE; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK; SUPEROXIDE DISMUTASE; VALINE;

EID: 59349088582     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9943-x     Document Type: Article

References (16)

1. Freedman BI, Bostrom M, Daeihagh P et al (2007) Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2(6):1306-1316. doi: 10.2215/ CJN.02560607
2. Brownlee M (2001) Biochemistry and molecular cell biology of diabetes complications. Nature 414:813-820. doi: 10.1038/414813a
3. Nishikawa T, Edelstein D, Du XL et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790. doi: 10.1038/35008121
4. Maritm AC, Sanders RA, Watkins JB (2003) Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 17(1):24-38. doi: 10.1002/ jbt.10058
5. Newsholme P, Haber EP, Hirabara SM et al (2007) Diabetes associated cell stress and dysfunction: Role of mitochondrial and non-mitochondrial ROS production and activity. J Phys 583(Pt 1):9-24. doi: 10.1113/ jphysiol.2007.135871
6. Sutton A, Khoury H, Prip-Buus C et al (2003) The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 13:145-157. doi: 10.1097/ 00008571-200303000-00004
7. Shimoda-Matsubayashi S, Matsumine H, Kobayashi T et al (1996) Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun 226:561-565. doi: 10.1006/bbrc.1996.1394
8. Nomiyama T, Tanaka Y, Piao L et al (2003) The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 48:138-141
9. Lee SJ, Choi MG, Kim DS, Kim TW et al (2006) Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism 55:1-7. doi: 10.1016/j.metabol.2005.04.030
10. Möllsten A, Marklund SL, Wessman M et al (2007) A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 56(1):265-269. doi: 10.2337/db06-0698
11. Nakanishi S, Yamane K, Ohishi W et al (2008) Manganese superoxide dismutase Ala16Val polymorphism is associated with the development of type 2 diabetes in Japanese-Americans. Diabetes Res Clin Pract 81(3):381-385. doi: 10.1016/j.diabres.2008.06.003
12. The Expert committee on the Diagnosis and Classification of Diabetes Mellitus (Position statement) (2003) Diabetes Care 26(suppl l): S5-S20
13. Molitch ME, DeFronzo RA, Franz MJ et al (2004) American Diabetes Association. Nephropathy in diabetes. Diabetes Care 27(suppl l):S79-S83. doi: 10.2337/diacare.27.5.1240-a
14. Sharma R, Sharma M, Datta PK et al (2002) Induction of metallothionein-I protects glomeruli from superoxide-mediated increase in albumin permeability. Exp Biol Med (Maywood) 227(1):26-31
15. Wolf G, Ziyadeh FN (2007) Cellular and molecular mechanism of proteinuria in diabetic nephropathy. Nephron Physiol 106(2):26-31. doi: 10.1159/000101797
16. McCord JM, Fridovich I (1988) Superoxide dismutase: The first twenty years (1968-1988). Free Radic Biol Med 5(5-6):363-369. doi: 10.1016/ 0891-5849(88)90109-8